Suppr超能文献

感觉运动白质组织的自然变异会影响亨廷顿舞蹈病的表现。

Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.

作者信息

Orth Michael, Gregory Sarah, Scahill Rachael I, Mayer Isabella Sm, Minkova Lora, Klöppel Stefan, Seunarine Kiran K, Boyd Lara, Borowsky Beth, Reilmann Ralf, Bernhard Landwehrmeyer G, Leavitt Blair R, Roos Raymund Ac, Durr Alexandra, Rees Geraint, Rothwell John C, Langbehn Douglas, Tabrizi Sarah J

机构信息

Department of Neurology, Ulm University Hospital, Ulm, Germany.

Wellcome Trust Centre for Neuroimaging, University College London, London, United Kingdom.

出版信息

Hum Brain Mapp. 2016 Dec;37(12):4615-4628. doi: 10.1002/hbm.23332. Epub 2016 Aug 1.

Abstract

While the HTT CAG-repeat expansion mutation causing Huntington's disease (HD) is highly correlated with the rate of pathogenesis leading to disease onset, considerable variance in age-at-onset remains unexplained. Therefore, other factors must influence the pathogenic process. We asked whether these factors were related to natural biological variation in the sensory-motor system. In 243 participants (96 premanifest and 35 manifest HD; 112 controls), sensory-motor structural MRI, tractography, resting-state fMRI, electrophysiology (including SEP amplitudes), motor score ratings, and grip force as sensory-motor performance were measured. Following individual modality analyses, we used principal component analysis (PCA) to identify patterns associated with sensory-motor performance, and manifest versus premanifest HD discrimination. We did not detect longitudinal differences over 12 months. PCA showed a pattern of loss of caudate, grey and white matter volume, cortical thickness in premotor and sensory cortex, and disturbed diffusivity in sensory-motor white matter tracts that was connected to CAG repeat length. Two further major principal components appeared in controls and HD individuals indicating that they represent natural biological variation unconnected to the HD mutation. One of these components did not influence HD while the other non-CAG-driven component of axial versus radial diffusivity contrast in white matter tracts were associated with sensory-motor performance and manifest HD. The first component reflects the expected CAG expansion effects on HD pathogenesis. One non-CAG-driven component reveals an independent influence on pathogenesis of biological variation in white matter tracts and merits further investigation to delineate the underlying mechanism and the potential it offers for disease modification. Hum Brain Mapp 37:4615-4628, 2016. © 2016 Wiley Periodicals, Inc.

摘要

虽然导致亨廷顿舞蹈病(HD)的HTT CAG重复序列扩展突变与导致疾病发作的发病机制高度相关,但发病年龄仍存在相当大的差异,无法解释。因此,其他因素必定会影响致病过程。我们询问这些因素是否与感觉运动系统的自然生物学变异有关。对243名参与者(96名症状前和35名症状期HD患者;112名对照)进行了感觉运动结构MRI、纤维束成像、静息态fMRI、电生理学(包括SEP振幅)、运动评分以及作为感觉运动表现的握力测量。在进行个体模态分析后,我们使用主成分分析(PCA)来识别与感觉运动表现以及症状期与症状前HD鉴别相关的模式。我们未检测到12个月内的纵向差异。PCA显示尾状核、灰质和白质体积减少,运动前区和感觉皮层的皮质厚度变薄,以及与CAG重复长度相关的感觉运动白质束扩散异常的模式。另外两个主要主成分出现在对照组和HD个体中,表明它们代表了与HD突变无关的自然生物学变异。其中一个成分不影响HD,而另一个非CAG驱动的白质束轴向与径向扩散率对比成分与感觉运动表现和症状期HD相关。第一个成分反映了预期的CAG扩展对HD发病机制的影响。一个非CAG驱动的成分揭示了白质束生物学变异对发病机制的独立影响,值得进一步研究以阐明其潜在机制及其在疾病修饰方面的潜力。《人类大脑图谱》37:4615 - 4628,2016年。© 2016威利期刊公司。

相似文献

1
Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.
Hum Brain Mapp. 2016 Dec;37(12):4615-4628. doi: 10.1002/hbm.23332. Epub 2016 Aug 1.
2
Natural biological variation of white matter microstructure is accentuated in Huntington's disease.
Hum Brain Mapp. 2018 Sep;39(9):3516-3527. doi: 10.1002/hbm.24191. Epub 2018 Apr 22.
3
Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
Hum Brain Mapp. 2017 Oct;38(10):5035-5050. doi: 10.1002/hbm.23713. Epub 2017 Jun 28.
4
Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration.
Hum Brain Mapp. 2017 Mar;38(3):1460-1477. doi: 10.1002/hbm.23465. Epub 2017 Jan 3.
5
Motor network structure and function are associated with motor performance in Huntington's disease.
J Neurol. 2016 Mar;263(3):539-49. doi: 10.1007/s00415-015-8014-y. Epub 2016 Jan 13.
7
Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
Hum Brain Mapp. 2018 Oct;39(10):3871-3883. doi: 10.1002/hbm.24217. Epub 2018 May 24.
8
Early grey matter changes in structural covariance networks in Huntington's disease.
Neuroimage Clin. 2016 Oct 12;12:806-814. doi: 10.1016/j.nicl.2016.10.009. eCollection 2016.
9
Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease.
Mov Disord. 2016 Nov;31(11):1664-1675. doi: 10.1002/mds.26803. Epub 2016 Sep 13.
10
Multimodal characterization of the visual network in Huntington's disease gene carriers.
Clin Neurophysiol. 2019 Nov;130(11):2053-2059. doi: 10.1016/j.clinph.2019.08.018. Epub 2019 Aug 28.

引用本文的文献

1
Diffusion imaging in Huntington's disease: comprehensive review.
J Neurol Neurosurg Psychiatry. 2020 Oct 8;92(1):62-9. doi: 10.1136/jnnp-2020-324377.
2
Longitudinal Structural MRI in Neurologically Healthy Adults.
J Magn Reson Imaging. 2020 Nov;52(5):1385-1399. doi: 10.1002/jmri.27203. Epub 2020 May 29.
3
Characterizing White Matter in Huntington's Disease.
Mov Disord Clin Pract. 2019 Nov 28;7(1):52-60. doi: 10.1002/mdc3.12866. eCollection 2020 Jan.
4
Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
J Neurol. 2019 Mar;266(3):551-564. doi: 10.1007/s00415-018-8940-6. Epub 2018 Jun 28.
5
Natural biological variation of white matter microstructure is accentuated in Huntington's disease.
Hum Brain Mapp. 2018 Sep;39(9):3516-3527. doi: 10.1002/hbm.24191. Epub 2018 Apr 22.

本文引用的文献

1
Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.
Cell. 2015 Jul 30;162(3):516-26. doi: 10.1016/j.cell.2015.07.003.
2
Prefrontal cortex white matter tracts in prodromal Huntington disease.
Hum Brain Mapp. 2015 Oct;36(10):3717-32. doi: 10.1002/hbm.22835. Epub 2015 Jul 14.
4
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Lancet Neurol. 2014 Dec;13(12):1193-201. doi: 10.1016/S1474-4422(14)70238-8. Epub 2014 Nov 3.
5
Targets for future clinical trials in Huntington's disease: what's in the pipeline?
Mov Disord. 2014 Sep 15;29(11):1434-45. doi: 10.1002/mds.26007. Epub 2014 Aug 25.
6
Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington's disease.
Psychol Med. 2014 Nov;44(15):3341-56. doi: 10.1017/S0033291714000579. Epub 2014 Mar 27.
7
Identification and interpretation of microstructural abnormalities in motor pathways in adolescents born preterm.
Neuroimage. 2014 Feb 15;87:209-19. doi: 10.1016/j.neuroimage.2013.10.034. Epub 2013 Oct 31.
9
Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials.
Neurosci Biobehav Rev. 2013 Mar;37(3):480-90. doi: 10.1016/j.neubiorev.2013.01.022. Epub 2013 Jan 29.
10
Axonopathy in Huntington's disease.
Exp Neurol. 2013 Aug;246:62-71. doi: 10.1016/j.expneurol.2012.08.010. Epub 2012 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验